The rapid increase in the prevalence of type 2 diabetes and obesity, coined by experts as “diabesity”, has led to diabesity being recognised as an epidemic in Europe. A new UK survey of 300 GPs and nurses and 1,001 individuals with type 2 diabetes and obesity funded by Bristol Myers-Squibb and AstraZeneca, found that both healthcare professionals and patients agreed that controlling weight is the most challenging aspect of type 2 diabetes management. It also highlights the vital role of healthcare professionals in prompting patients to take action over their diet and exercise during routine appointment times. Of the 1,001 people with diabetes and obesity surveyed, 60% said that they follow healthcare professional recommendations on diet and exercise. This compares to just 35% following advice from family members and 25% advice from friends. Despite this, 83% of patients admit they are still not happy with their weight and the same proportion (83%) worry about how it will affect their future health. Professor David Haslam, GP and Chair of the National Obesity Forum, said: “We are facing a diabesity crisis and ultimately, treating diabetes without addressing weight loss is futile. From the survey we know that patients are keen to control their weight and follow the advice they receive from healthcare professionals over the advice they receive from others.” Type 2 diabetes currently affects around 2.6 million people in the UK, with recent estimates showing that the NHS spends £9 billion annually (10% of its budget) treating diabetes and its complications.